Glycine Transport Inhibitors for the Treatment of Schizophrenia

Multiple lines of evidence indicate that hypofunction of glutamatergic neurotransmission via N-methyl-D-aspartate (NMDA) receptors might be implicated in the pathophysiology of schizophrenia, suggesting that increasing NMDA receptor function via pharmacological manipulation could provide a new strat...

Descripción completa

Detalles Bibliográficos
Autor principal: Hashimoto, Kenji
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023951/
https://www.ncbi.nlm.nih.gov/pubmed/21253021
http://dx.doi.org/10.2174/1874104501004010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023951/
https://www.ncbi.nlm.nih.gov/pubmed/21253021
http://dx.doi.org/10.2174/1874104501004010010

Ejemplares similares